Monday, 15 June 2020

Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients

Eli Lilly and Co on Monday said it was launching a study of its rheumatoid arthritis drug baricitinib in patients hospitalized for COVID-19.


from Reuters: Health https://ift.tt/3d4cbFm

No comments:

Post a Comment